Targeting Acute Myelogenous Leukemia Using PotentHuman Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety. This evidence concerns the gene DHODH and acute myeloid leukemia.